Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial-Reference-Cited by-同舟云学术

Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial

Published:2014-04 Issue:19 Volume:32 Page:2241-2250
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Gavilondo J.V.,Hernández-Bernal F.,Ayala-Ávila M.,de la Torre A.V.,de la Torre J.,Morera-Díaz Y.,Bequet-Romero M.,Sánchez J.,Valenzuela C.M.,Martín Y.,Selman-Housein K.-H.,Garabito A.,Lazo O.C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference62 articles.

1. Angiogenesis: an organizing principle for drug discovery?;Folkman;Nat Rev Drug Discov,2007

2. Tumor angiogenesis: therapeutic implications;Folkman;N Engl J Med,1971

3. Angiogenesis and apoptosis;Folkman;Semin Cancer Biol,2003

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

5. Sunitinib malate for the treatment of solid tumours: a review of current clinical data;Motzer;Expert Opin Investig Drugs,2006

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Bacterial and Ganglioside-based Nanoparticle Initiates Reprogramming of Macrophages and Promotes Antitumor Phenotypes;The Journal of Immunology;2023-12-20

2. Therapeutic Cancer Vaccines for the Management of Recurrent and Metastatic Head and Neck Cancer;JAMA Otolaryngology–Head & Neck Surgery;2023-02-01

3. Immune Deprivation of Growth Factors as Cancer Therapy;Handbook of Cancer and Immunology;2023

4. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator;Journal for ImmunoTherapy of Cancer;2022-09

5. Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived free-VEGF;Platelets;2022-04-03